FX

GBP/USD has been marching higher in hopes of a Brexit deal. Vaccine news is to continue competing with covid statistics in a new week set to be dominated mostly by Brexit once again. The Federal Reserve’s minutes, updated US growth figures and forward-looking UK surveys will be also eyed, FXStreet’s Analyst Yohay Elam reports.  Key
The US oil storage tanks are filling up again amid the rising number of coronavirus cases and approaching levels reached following April’s oil price crash, according to Bloomberg.  Stockpiles at Cushing, Oklahoma, the delivery point for West Texas Intermediate (WTI) futures, stood at 61.6 million barrels as of Nov. 13, or about 81% of capacity
Gold has been under pressure in recent days, hit most recently by news that AstraZeneca is joining Moderna and Pfizer/BioNTech in reporting upbeat vaccine results. If the world is heading toward immunization from COVID-19, the need for fiscal and monetary stimulus is diminishing.  On the other hand, the virus continues spreading, causing economic damage which
AUD/USD fails to respect highly positive Aussie employment report as risk dwindles. One-week-old horizontal support can add to the downside filters, 0.7340/45 becomes the key resistance. AUD/USD remains depressed near 0.7290, down 0.10% intraday, during the early Thursday. The pair earlier bounced off an intraday low after Australia’s October month employment data offered a positive
Silver prices have been choppy on Wednesday, swinging between gains and losses, and recovering sharply from late European morning lows at $24.20. XAG/USD has been consolidating within a pennant structure this month and looks subject to breakout.    Spot silver prices (XAG/USD) have been choppy on Wednesday, swinging between gains and losses, but have broadly continued
NZD/USD dips as risk sentiment sours on coronavirus concerns.  Rising cases overshadow optimism stemming from encouraging vaccine trials.  Dovish Federal Reserve expectations restrict losses in Kiwi. NZD/USD is flashing red on Tuesday as concerns over rising coronavirus cases and prospects of fresh lockdowns dampen the euphoria from vaccine trial breakthroughs. The pair is currently trading
Here is what you need to know on Monday, November 16:  The US continues to report record coronavirus infections. On  Friday, the country informed over 184K new cases in the past 24 hours, while US President Donald Trump announced the imminent distribution of COVID-19 vaccines. The announcement was taken with a pinch of salt and
EUR/GBP rebound from 0.8860, rejected at 0.9000. The pound appreciates after UK’s top adviser Cummings announces his exit. Euro’s recovery from week-lows at 0.8860 has been rejected at 0.9000 and the pair pulled back to 0.8960 area on Friday, on track to close the week with a 0.7% loss. The sterling appreciates as Brexit deal
WTI drops as coronavirus resurgence in the US revives lockdown fears.  OPEC+ is reportedly considering a three to six-month delay to a scheduled output boost.  The US oil prices fell during Friday’s Asian trading hours, extending a two-day losing trend as concerns over rising coronavirus infection overshadowed reports of major producers mulling a delay in
Gold regained traction on Thursday and recovered the previous session’s modest losses. COVID-19 jitters, sliding US bond yields, weaker USD remained supportive of the uptick. Investors might refrain from placing aggressive bets ahead of Powell’s scheduled speech. Gold edged higher during the early North American session and refreshed daily tops, around the $1880 region post-US macro